63 Publications (Page 1 of 3)
Development and application of high-throughput screens for the discovery of compounds that disrupt ErbB4 signaling: Candidate cancer therapeutics
Cullum, Richard LCullum, Richard LLucas, Lauren MLucas, Lauren MSenfeld, Jared ISenfeld, Jared IPiazza, John TPiazza, John TNeel, Logan TNeel, Logan TWhig, KanupriyaWhig, KanupriyaZhai, LingZhai, LingHarris, Mackenzie HHarris, Mackenzie HRael, Cristina CRael, Cristina CTaylor, Darby CTaylor, Darby CCook, Laura JCook, Laura JKaufmann, David PKaufmann, David PMill, Christopher PMill, Christopher PJacobi, Megan AJacobi, Megan ASmith, Forrest TSmith, Forrest TSuto, MarkSuto, MarkBostwick, RobertBostwick, RobertGupta, Ram BGupta, Ram BDavid, Allan EDavid, Allan ERiese, David J and Riese, David J
PLoS One, vol. 15, (no. 12), Dec 2020. | Journal Article
Abstract 1245: Screening methodologies for the discovery of small molecule melanoma therapeutics targeted at the ErbB4 receptor tyrosine kinase
Cullum, Richard LCullum, Richard LPiazza, John TPiazza, John TSenfeld, Jared ISenfeld, Jared INeel, Logan TNeel, Logan TGupta, Ram BGupta, Ram BDavid, Allan EDavid, Allan ERiese, David J and Riese, David J
Cancer Research, vol. 77, (no. 13 Supplement), pp. 1245, 2017-07-01. | Journal Article
Estrogen receptor-α, progesterone receptor, and c-erbB/HER-family receptor mRNA detection and phenotype analysis in spontaneous canine models of breast cancer
Kabir, Farruk M. LutfulDeInnocentes, PatriciaAgarwal, PayalMill, Christopher PRiese, David J and Bird, R. Curtis
Journal of Veterinary Science, vol. 18, (no. 2), pp. 158, 2017-00-00. | Journal Article
Abstract 1353: Validation and implementation of screens for partial agonists and antagonists of the ErbB4/HER4 receptor tyrosine kinase: Targeted melanona drug discovery
Cullum, RichardDavid, Allan and Riese, David J
Cancer Research, vol. 76, (no. 14 Supplement), pp. 1353, 2016-07-15. | Journal Article
Expression and purification of HER2 extracellular domain proteins in Schneider2 insect cells
Kanthala, ShanthiKanthala, ShanthiMill, Christopher PMill, Christopher PRiese, David JRiese, David JJaiswal, MihirJaiswal, MihirJois, Seetharama and Jois, Seetharama
Protein Expression and Purification, vol. 125, pp. 33, September 2016. | Journal Article
Abstract B17: A high-throughput screening process for the discovery of melanoma chemotherapeutics targeted at the ErbB4 receptor tyrosine kinase
Cullum, Richard LGupta, Ram B and Riese, David J
Cancer Research, vol. 75, (no. 14 Supplement), pp. B17, 2015-07-15. | Journal Article
Epiregulin: Roles in normal physiology and cancer
Riese, David J and Cullum, Richard L
Seminars in Cell and Developmental Biology, vol. 28, pp. 56, April 2014. | Journal Article
Autocrine-derived epidermal growth factor receptor ligands contribute to recruitment of tumor-associated macrophage and growth of basal breast cancer cells in vivo.
Nickerson, Nicole KMill, Christopher PWu, Hsin-JungRiese, David J and Foley, John
Oncology research, vol. 20, (no. 7), pp. 303-17, 2013. | Journal Article
PALAIOS, vol. 28, (no. 2), pp. 128, 2013. | Journal Article
At the crossroads: EGFR and PTHrP signaling in cancer-mediated diseases of bone.
Foley, John GNickerson, NicoleRiese, David JHollenhorst, Peter CLorch, Gwendolen and Foley, Anne M
Odontology / the Society of the Nippon Dental University, vol. 100, (no. 2), pp. 109-29, 2012/Jul. | Journal Article
EGFR ligands exhibit functional differences in models of paracrine and autocrine signaling.
Wilson, Kristy JMill, ChristopherLambert, SydneyBuchman, JenniferWilson, Timothy RHernandez-Gordillo, VictorGallo, Richard MAdes, Laura MSettleman, Jeffrey E and Riese, David J
Growth factors (Chur, Switzerland), vol. 30, (no. 2), pp. 107-16, 2012/Apr. | Journal Article
The Q43L mutant of neuregulin 2β is a pan-ErbB receptor antagonist.
Wilson, Kristy JMill, Christopher PGallo, Richard MCameron, Elizabeth MVan Brocklin, HenrySettleman, Jeffrey E and Riese, David J
The Biochemical journal, vol. 443, (no. 1), pp. 133-44, 2012/Apr/1. | Journal Article
A high throughput, interactive imaging, bright-field wound healing assay
Zordan, Michael DMill, Christopher PRiese, David J and Leary, James F
Cytometry Part A, vol. 79A, (no. 3), pp. 227-232, 2011. | Journal Article
A high throughput, interactive imaging, bright-field wound healing assay.
Zordan, Michael DMill, Christopher PRiese, David J and Leary, James F
Cytometry. Part A : the journal of the International Society for Analytical Cytology, vol. 79, (no. 3), pp. 227-32, 2011/Mar. | Journal Article
ErbB2 Is Necessary for ErbB4 Ligands to Stimulate Oncogenic Activities in Models of Human Breast Cancer.
Mill, Christopher PZordan, Michael DRothenberg, S MSettleman, Jeffrey ELeary, James F and Riese, David J
Genes & cancer, vol. 2, (no. 8), pp. 792-804, 2011/Aug. | Journal Article
Ligand-based receptor tyrosine kinase partial agonists: new paradigm for cancer drug discovery?
Riese, David J
Expert Opinion on Drug Discovery, vol. 6, (no. 2), pp. 185-193, 2011. | Journal Article
Ligand stimulation of ErbB4 and a constitutively-active ErbB4 mutant result in different biological responses in human pancreatic tumor cell lines
Mill, Christopher PGettinger, Kathleen L and Riese, David J
Experimental Cell Research, vol. 317, (no. 4), pp. 392-404, Feb 15, 2011. | Journal Article
EGFR signaling in breast cancer: Bad to the bone
Foley, John GNickerson, Nicole KNam, SeungyoonAllen, Kah TGilmore, Jennifer LNephew, Ken and Riese, David J
Seminars in Cell & Developmental Biology, vol. 21, (no. 9), pp. 951-960, 2010. | Journal Article
Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant
Frogne, ThomasBenjaminsen, Rikke VSonne-hansen, KatrineSørensen, Boe SandahlNexø, EbbaLaenkholm, Anne-vibekeRasmussen, Louise MRiese, David Jde Cremoux, PatriciaStenvang, Jan and Lykkesfeldt, Anne E
Breast Cancer Research and Treatment, vol. 114, (no. 2), pp. 263-75, Mar 2009. | Journal Article
Altered EGFR localization and degradation in human breast cancer cells with an amphiregulin/EGFR autocrine loop.
Willmarth, Nicole EBaillo, AndreaDziubinski, Michele LWilson, KristyRiese, David J and Ethier, Stephen P
Cellular signalling, vol. 21, (no. 2), pp. 212-9, 2009/Feb. | Journal Article
EGFR may couple moderate alcohol consumption to increased breast cancer risk
Riese, David
Breast Cancer: Targets and Therapy, vol. 1, (no. default), pp. 38, 2009-10-00. | Journal Article
Functional selectivity of EGF family peptide growth factors: implications for cancer.
Wilson, Kristy JGilmore, Jennifer LFoley, John GLemmon, Mark A and Riese, David J
Pharmacology & therapeutics, vol. 122, (no. 1), pp. 1-8, 2009/Apr. | Journal Article
Lowe syndrome patient fibroblasts display Ocrl1-specific cell migration defects that cannot be rescued by the homologous Inpp5b phosphatase
Coon, Brian GCoon, Brian GMukherjee, DebaratiMukherjee, DebaratiHanna, Claudia BHanna, Claudia BRiese, David JRiese, David JLowe, MartinLowe, MartinAguilar, Claudio R and Aguilar, R. Claudio
Human Molecular Genetics, vol. 18, (no. 23), pp. 4491, 20091201. | Journal Article
Reconstitution of amphiregulin-epidermal growth factor receptor signaling in lung squamous cell carcinomas activates PTHrP gene expression and contributes to cancer-mediated diseases of the bone.
Gilmore, Jennifer LGonterman, Ryan MMenon, KeshavLorch, GwendolenRiese, David JRobling, Alexander and Foley, John G
Molecular cancer research : MCR, vol. 7, (no. 10), pp. 1714-28, 2009/Oct. | Journal Article
Amphiregulin-EGFR signaling regulates PTHrP gene expression in breast cancer cells
Gilmore, Jennifer LScott, Jeffrey ABouizar, ZhorRobling, AlexanderPitfield, Sarah ERiese, David J and Foley, John G
Breast Cancer Research and Treatment, vol. 110, (no. 3), pp. 493-505, Aug 2008. | Journal Article